WHO advises 2 monoclonal antibodies for severe COVID Leave a Comment / By nigel / July 6, 2021 Lisa Schnirring | News Editor | CIDRAP News Jul 06, 2021 Study finds that tocilizumab and sarilumab reduce the risk of death and the need for mechanical ventilation.